Filamin A interacts with the co-activator MKL1 to promote the activity of transcription factor SRF and PDF
Preview Filamin A interacts with the co-activator MKL1 to promote the activity of transcription factor SRF and
Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwigs-‐Maximilians-‐Universität München Filamin A interacts with the co-‐activator MKL1 to promote the activity of transcription factor SRF and cell migration Philipp Oliver Kircher aus Weilheim i OB 2016 Erkärung Erklärung: Diese Dissertation wurde im Sinne von §7 der Promotionsordnung vom 28. November 2011 von Herrn Prof. Dr. Thomas Gudermann betreut und von Herrn Prof. Dr. Martin Biel von der Fakultät für Chemie und Pharmazie vertreten. Eidesstattliche Versicherung: Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. München, den 12.05.2016 ______________________ Philipp Kircher Dissertation eingereicht am 02.06.2016 1. Gutachter: Herr Prof. Dr. Martin Biel 2. Gutachter: Herr Prof. Dr. Thomas Gudermann Mündliche Prüfung am 18.07.2016 2 Table of Content Table of content 1 Summary 8 2 Introduction 9 2.1 Megakaryoblastic Leukemia 1: A first look and brief history 9 2.2 Serum Response factor (SRF): Engine of transcriptional activity and director of elementary biological functions 10 2.2.1 Serum Response factor (SRF): Two different pathways of activation 13 2.2.1.1 The ternary complex factor (TCF) dependent signaling pathway 13 2.2.1.2 The Rho-‐actin signaling pathway and cytoskeleton actin dynamics 14 2.2.1.3 SRF activating pathways in comparison: A competition for cell development 16 2.2.1.4 Rho in cancer development and the tumor suppressor DLC1 16 2.3 Myocardin-‐related transcription factors: A closer insight 17 2.3.1 Myocardin-‐related transcription factors: Structure 17 2.3.2 Myocardin-‐related transcription factors: Subcellular localization 19 2.4 Filamin A: Rising of a new MKL1 interaction partner 21 2.4.1 The cytoskeleton: A cell stabilizer and more 21 2.4.2 The family of the filamins: Structure 22 2.4.3 The family of the filamins: Broad variety of functions 23 2.4.4 The family of the filamins: Pathogenesis and tumorigenesis 25 3 Aim of the thesis 28 4 Materials 29 4.1 Cell culture 29 3 Table of Content 4.1.1 Cell lines 29 4.1.2 Cell culture media and solutions 30 4.1.3 Transfection reagents 30 4.1.4 Plasmid constructs 31 4.1.5 siRNA sequences 33 4.1.6 Selection antibiotic for cell culture 34 4.1.7 Inhibitors and stimulants 34 4.2 Antibodies 35 4.2.1 Primary antibodies 35 4.2.2 Secondary antibodies 36 4.3 Nucleotides 36 4.3.1 Random Hexamers 36 4.3.2 Real-‐time PCR primers 37 4.4 Bacterial strains and media 38 4.5 Kits 39 4.6 Reagents 39 4.7 Enzymes 40 4.8 Buffers and solutions 41 4.8.1 cDNA synthesis/ RT-‐PCR 41 4.8.2 Protein analysis 41 4.9 Chemicals 46 4.10 Technical devices and other equipment 49 4 Table of Content 5 Methods 51 5.1 Cell culture methods 51 5.1.1 Culturing and maintenance of eukaryotic cell lines 51 5.1.2 Liposomal transient transfection 51 5.1.3 Calcium-‐phosphate transient transfection 52 5.1.4 siRNA transient transfection 52 5.1.5 Serum starvation 53 5.1.6 Serum stimulation 53 5.1.7 Drug treatment 53 5.1.8 Cell harvest and lysis 53 5.2 Protein biochemistry 54 5.2.1 Determination of total protein concentration 54 5.2.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-‐PAGE) 54 5.2.3 Immunoblotting 55 5.2.4 Immunoprecipitation 56 5.2.5 Indirect Immunofluorescence 56 5.3 Scratch-‐wound assay 57 5.4 Invasion assay 57 5.5 Nucleic acid biochemistry 57 5.5.1 RNA isolation 57 5.5.2 cDNA synthesis 58 5.5.3 Real-‐time PCR 58 5 Table of Content 5.5.4 Generation of ΔMKL1 mutants 60 5.5.5 Transformation into chemically competent E.coli DH5alpha bacteria cells 61 5.5.6 Midi scale plasmid preparation 61 5.6 Luciferase reporter assay 62 5.7 Statistical analysis 62 5.8 Software and databases 62 6 Results 63 6.1 Identification of FLNA as a novel MKL1 interacting protein 63 6.2 Mapping of MKL1-‐FLNA binding sites 70 6.3 The dynamic MKL1-‐FLNA interaction, its correlation with the induction and repression of MKL1-‐SRF target genes and phosphorylation influence 77 6.4 Identification of FLNA as a transducer of actin polymerization to SRF activity 85 6.5 Interaction of FLNA and MKL1 in cell migration and invasion 93 6.6 Interaction of FLNA and MKL1 in the expression of MKL1 target genes 98 7 Discussion 105 7.1 Identification of a novel MKL1 interacting protein: Impact of the new MKL1-‐FLNA interaction on cellular functions 105 7.1.1 Consequences and biological effects of the MKL1-‐FLNA binding 105 7.1.2 Localization of the MKL1-‐FLNA binding and potential DLC1 influence 106 7.1.3 MKL1 shuttling affected by FLNA? 107 7.1.4 RhoA-‐actin signaling activating and inhibiting drugs and its functional effects on the MKL1-‐FLNA interaction 108 6 Table of Content 7.2 Rounding the puzzle: Where do MKL1 and FLNA gear? 110 7.2.1 MKL1 interacting region on FLNA 110 7.2.2 FLNAs unique structure-‐properties simplifying MKL1 association? 113 7.2.3 Force, mechanical stress and a potential influence on MKL1 binding nature 114 7.2.4 FLNA interacting region on MKL1 115 7.3 Actin in control. Role of actin in the FilaminA-‐MKL1 machinery 116 7.3.1 Possible formation of a trimeric MKL1-‐FLNA-‐F-‐actin complex 116 7.3.2 G-‐actin terminating MKL1-‐FLNA machinery? 117 7.3.3 Linking actin dynamics to state of the art drug development 118 7.3.4 The formin mDia as the missing key in launching MKL1-‐FLNA-‐F-‐actin complex activity? 119 7.3.5 Mechanistic summary of the MKL1-‐FLNA association 120 7.4 MKL1 and FLNA: A highly dynamic duo leading to cancer 121 7.5 The many faces of MKL1 and FLNA: Final thoughts and a link to neuronal diseases 125 8 Figures 127 9 Tables 131 10 Abbreviation index 132 11 References 135 12 Publications 147 13 Acknowledgements 148 7 Summary 1 Summary Megakaryoblastic Leukemia 1 (MKL1, MRTF-‐A, MAL) is a transcriptional co-‐activator of Serum response factor (SRF) that promotes the expression of genes involved in cell proliferation, motility, adhesion and differentiation-‐processes. It thereby holds an essential part in controlling fundamental biological processes like heart, cardiovascular system or brain development. MKL1 is inactive when bound to monomeric actin (G-‐actin), thus nuclear access is denied. However, signals that activate the small GTPase RhoA cause actin polymerization (F-‐actin) and MKL1 dissociation from G-‐actin, this way allowing successful MKL1 shuttling into the nucleus and conveying signals from RhoA into SRF activity. Filamin A (FLNA) belongs to the group of actin-‐binding proteins. It is indispensable for filamentous F-‐actin cross-‐linking, thus contributes to cytoskeletal dynamics, cell mobility and stability in a crucial way. In this work, we found a new central mechanism of MKL1 activation that is mediated through its binding to FLNA as a novel interaction partner. We provide evidence that the interaction of MKL1 and FLNA is required for the expression of MKL1 target genes and MKL1-‐ dependent cell motility. We map MKL1 and FLNA regions responsible for the interaction and demonstrate, that cells expressing a MKL1 mutant unable to bind FLNA showed reduced expression of MKL1 target genes and impaired cell motility. Furthermore we indicate that induction and repression of MKL1 target genes correlate with increased or decreased quantity of the MKL1-‐FLNA interaction. A dynamic flow was revealed, as lysophosphatidic acid-‐induced RhoA activity in primary human fibroblasts promoted the association of endogenous MKL1 with FLNA, whereas exposure to an actin polymerization inhibitor dissociated MKL1 from FLNA and decreased MKL1 target gene expression in melanoma cells. Thus FLNA binding to MKL1 functions as a novel cellular transducer linking actin polymerization to SRF activity, counteracting the known repressive complex of MKL1 and monomeric G-‐actin, which advances to our mechanistic understanding of MKL1 regulation. 8 Introduction 2 Introduction 2.1 Megakaryoblastic Leukemia 1: A first look and brief history Versatility and specificity in gene regulation is achieved with the association of transcriptional co-‐activators with specific DNA-‐binding proteins. Megakaryoblastic Leukemia 1 (MKL1, MRTF-‐A, MAL) is a strong transcriptional co-‐activator, which has been introduced for the first time as a trigger for acute megakaryoblastic leukemia (AMKL), a rare and aggressive form of childhood leukemia (Mercher T., Coniat MB. et al, 2001). AMKL's signature trademark is the stoppage of thrombocytes development during the stage of immature megakaryoblasts. Formation of a MKL1 fusion protein (RBM15-‐MKL1/ RNA-‐ binding motif protein 15 or OTT-‐MAL/ one-‐twenty-‐two-‐myeloid acute leukemia) is expected to be the cause. In contrast to regular MKL1, RBM15-‐MKL1 acts independently of G-‐actin, which naturally controls MKL1 shuttling mechanism in and out of the nucleus. Therefore, RBM15-‐MKL1 remains in the nucleus, resulting in a non-‐stop stimulation of MKL1 target genes, thus promoting tumor progression (Descot A., Rex-‐Haffner M. et al, 2008). Besides the involvement of MKL1 in acute megakaryoblastic leukemia, MKL1 is also required for tumor cell invasion and metastasis since knockdown of MKL1 revoked cell invasion and motility of human breast carcinoma and mouse melanoma cells (Medjkane S., Perez-‐Sanchez C. et al, 2009). 9 Introduction Figure 1: (Left) Thrombocytes development/stoppage at stage of immature megakaryoblastics (red circle) in acute megakaryoblastic leukemia (AMKL). (Right) Formation of the RBM15-‐MKL1-‐fusion protein, which remains in the nucleus. Taken from Mercher et al, 2001; Posern et al, 2008. 2.2 Serum Response factor (SRF): Engine of transcriptional activity and director of elementary biological functions Transcription factors mediate genetic execution in response to cellular signals, this way playing major roles helping the cell adapting to changed demands. Serum response transcriptional factor (SRF) which is activated by MKL1, directly regulates the transcription of a large variety of genes involved in cell proliferation, cell motility, cell adhesion, cell differentiation and organization of the cytoskeleton (Johansen FE., Prywes R., 1995; Treisman R., 1986). This way the MKL1/SRF complex obtains an essential part in controlling fundamental biological processes like heart, muscle, cardiovascular system or brain 10
Description:The list of books you might like
